Form 4 for ACRV Acrivon Therapeutics, Inc.
Accepted 2025-08-18 00:00:00 ET · period of report 2025-08-14 · accession 0000905148-25-003039 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2025-08-18 | 2025-08-14 | ACRV | Masson Kristina | EVP - Business Ops, Dir | F - Tax | $1.39 | -490 | 315.2K | -0.2% | -$681.10 |
| 2025-08-18 | 2025-08-14 | ACRV | Masson Kristina | EVP - Business Ops, Dir | F - Tax | $1.39 | -59.8K | 2.15M | -3% | -$83.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-14 | F | D | 490 | $1.39 | 315,196 | I | — | — | |
| 2 | Common | Common Stock | 2025-08-14 | F | D | 59,766 | $1.39 | 2,146,345 | D See Footnote | — | — | (F2) These securities are held by President and CEO, Dr. Peter Blume-Jensen, who is also Dr. Kristina Masson's spouse. Dr. Masson disclaims beneficial ownership of such securities except to the extent of her pecuniary interest therein. (F3) These securities are held by co-founder and EVP, Dr. Kristina Masson, who is also Dr. Blume-Jensen's spouse. Dr. Blume-Jensen disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. |